Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 6
2012 5
2013 11
2014 6
2015 6
2016 6
2017 3
2018 4
2019 1
2020 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Individualization of antiretroviral therapy.
Pavlos R, Phillips EJ. Pavlos R, et al. Pharmgenomics Pers Med. 2012;5:1-17. doi: 10.2147/PGPM.S15303. Epub 2011 Dec 29. Pharmgenomics Pers Med. 2012. PMID: 23226059 Free PMC article.
Effect of rifampin and rifabutin on the pharmacokinetics of lersivirine and effect of lersivirine on the pharmacokinetics of rifabutin and 25-O-desacetyl-rifabutin in healthy subjects.
Vourvahis M, Davis J, Wang R, Layton G, Choo HW, Chong CL, Tawadrous M. Vourvahis M, et al. Antimicrob Agents Chemother. 2012 Aug;56(8):4303-9. doi: 10.1128/AAC.06282-11. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644026 Free PMC article. Clinical Trial.
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F; Adult AIDS Clinical Trials Group A5221 Study Team. Luetkemeyer AF, et al. Clin Infect Dis. 2013 Aug;57(4):586-93. doi: 10.1093/cid/cit246. Epub 2013 Apr 16. Clin Infect Dis. 2013. PMID: 23592830 Free PMC article.
44 results